Class III · Low risk Ongoing
Doxazosin Tablets
Reason Tablets/Capsules Imprinted with Wrong ID
Cardura XL
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.
What was recalled
Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30
- Recalling firm
- Pfizer Inc.
- NDC code
- 0049-2710-30
- Origin
- NY, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1485-2014
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Doxazosin recalls
See all
Class II · Moderate risk Terminated
Cardura XL
Reason Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Class II · Moderate risk Terminated
Cardura XL
Reason Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Class II · Moderate risk Completed
Cardura XL
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Completed
Cardura XL
Reason Failed Impurities/Degradation Specifications
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.